CHARACTERISTICS OF PATIENTS DIAGNOSED WITH CARDIAC TRANSTHYRETIN AMYLOIDOSIS BY TECHNETIUM PYROPHOSPHATE UPTAKE WITHIN A HEALTHCARE SYSTEM

Cardiac transthyretin amyloidosis (ATTR) is an underrecognized and underdiagnosed entity. With increasing clinical awareness and availability of non-invasive diagnostic testing, more patients are being identified early and can benefit from treatment. Our study examines the positive testing rate for